World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
107
Citations
33693
World Ranking
6341
National Ranking
3382

Zhongxing Liao publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Zhongxing Liao sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 831 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Zhongxing Liao D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Zhongxing Liao sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 107 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Zhongxing Liao is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily lies within the field of Medicine, with a significant focus on subfields including Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Oncology, Radiation, and Surgery.

The scientist's work covers various main topics, such as:

  • Lung Cancer Diagnosis and Treatment
  • Advanced Radiotherapy Techniques
  • Radiomics and Machine Learning in Medical Imaging
  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
  • Effects of Radiation Exposure
  • Esophageal Cancer Research and Treatment

Among recent publications associated with Zhongxing Liao are:

  • "The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression" (2020), published in Cell Research
  • "Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer" (2020), published in Nature Cancer
  • "Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery" (2021), published in The Lancet Oncology
  • "Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer" (2020), published in Journal of Clinical Oncology
  • "Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial" (2023), published in The Lancet

The scientist frequently collaborates with colleagues including Steven H. Lin, Ting Xu, Joe Y. Chang, Radhe Mohan, and Saumil Gandhi, suggesting a strong network within their field of study.

Publications have appeared in journals such as:

  • International Journal of Radiation Oncology*Biology*Physics
  • Radiotherapy and Oncology
  • Journal of Clinical Oncology
  • Journal of Thoracic Oncology
  • Clinical Lung Cancer

Zhongxing Liao has contributed to book publications, with a notable work titled Application of Radiomics in Understanding Tumor Biological Behaviors and Treatment Response, published by Frontiers Media in 2023.

Best Publications

  • The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression.

    Guang Lei;Guang Lei;Yilei Zhang;Pranavi Koppula;Xiaoguang Liu

  • Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT)

    Shulian Wang;Zhongxing Liao;Xiong Wei;Helen H. Liu

  • Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non–Small-Cell Lung Cancer

    James Welsh;Ritsuko Komaki;Arya Amini;Mark F. Munsell

  • Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications

    Alexander Chi;Zhong Xing Liao;Nam P. Nguyen;Jiahong Xu

  • Assessing Respiration-Induced Tumor Motion and Internal Target Volume Using Four-Dimensional Computed Tomography for Radiotherapy of Lung Cancer

    H. Helen Liu;Peter Balter;Teresa Tutt;Bum Choi

  • Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non–small-cell lung cancer

    Hasan Murshed;H.Helen Liu;Zhongxing Liao;Jerry L Barker

  • Respiratory-driven lung tumor motion is independent of tumor size, tumor location, and pulmonary function.

    Craig W Stevens;Reginald F Munden;Kenneth M Forster;Jason F Kelly

  • Influence of Technologic Advances on Outcomes in Patients With Unresectable, Locally Advanced Non-Small-Cell Lung Cancer Receiving Concomitant Chemoradiotherapy

    Zhongxing X. Liao;Ritsuko R. Komaki;Howard D. Thames;Helen H. Liu

  • Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.

    Sue S. Yom;Zhongxing Liao;H. Helen Liu;Susan L. Tucker

  • Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.

    Stephen G Swisher;Jack A Roth;Ritsuko Komaki;Jian Gu

  • Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.

    H.Helen Liu;Xiaochun Wang;Lei Dong;Qiuwen Wu

  • Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer.

    Xenia Fave;Lifei Zhang;Jinzhong Yang;Dennis Mackin

  • Attenuation Correction of PET Images with Respiration-Averaged CT Images in PET/CT

    Tinsu Pan;Osama Mawlawi;Sadek A. Nehmeh;Yusuf E. Erdi

  • Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes.

    Chad Tang;Zhongxing Liao;Daniel Gomez;Lawrence Levy

  • Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer

    Zhongxing Liao;J. Jack Lee;Ritsuko Komaki;Daniel R. Gomez

  • Propensity Score-based Comparison of Long-term Outcomes With 3-Dimensional Conformal Radiotherapy vs Intensity-Modulated Radiotherapy for Esophageal Cancer

    Steven Hsesheng Lin;Lu Wang;Bevan Myles;Peter F Thall

  • Evaluation of internal lung motion for respiratory-gated radiotherapy using MRI: Part I-Correlating internal lung motion with skin fiducial motion

    Nicholas Koch;H.Helen Liu;George Starkschall;Marc Jacobson

  • Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer.

    Joe Y Chang;Peter A Balter;Lei Dong;Qiuan Yang

  • Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.

    Shu Lian Wang;Zhongxing Liao;Ara A Vaporciyan;Susan L. Tucker

  • Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer

    Everett J. Moding;Yufei Liu;Barzin Y. Nabet;Jacob J. Chabon

Frequent Co-Authors

Ritsuko Komaki
Ritsuko Komaki The University of Texas MD Anderson Cancer Center
James D. Cox
James D. Cox The University of Texas MD Anderson Cancer Center
Radhe Mohan
Radhe Mohan The University of Texas MD Anderson Cancer Center
Joe Y. Chang
Joe Y. Chang The University of Texas MD Anderson Cancer Center
Pamela K. Allen
Pamela K. Allen The University of Texas MD Anderson Cancer Center
Jaffer A. Ajani
Jaffer A. Ajani The University of Texas MD Anderson Cancer Center
Susan L. Tucker
Susan L. Tucker The University of Texas MD Anderson Cancer Center
Wayne L. Hofstetter
Wayne L. Hofstetter The University of Texas MD Anderson Cancer Center
Stephen G. Swisher
Stephen G. Swisher The University of Texas MD Anderson Cancer Center
Ara A. Vaporciyan
Ara A. Vaporciyan The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in medicine opens the door to numerous related career pathways. Many students interested in healthcare fields are now exploring flexible online programs that can help them advance efficiently in their careers. One popular route is the online healthcare management degree, ideal for those wishing to move into healthcare leadership or administration.

Registered nurses seeking to expand their roles can consider specialized programs like adn to np bridge programs, which create a direct path to becoming a nurse practitioner. Likewise, prospective nutritionists and dietitians can benefit from enrolling in one of the best online nutrition programs to gain evidence-based knowledge and practical skills in nutritional science.

For those interested in higher-level administrative roles, pursuing one of the best mha programs provides advanced expertise in healthcare management, preparing graduates for executive positions in hospitals, clinics, and health organizations.

These related online degrees not only offer convenience and flexibility, but also address the growing demand for qualified professionals in a dynamic healthcare landscape.

Best Scientists Citing Zhongxing Liao

Trending Scientists

Recently Published Articles